ECTRIMS

What ECTRIMS does

ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis), founded in 1984 and headquartered in Basel, Switzerland, is the world's largest professional organization dedicated to advancing multiple sclerosis research, treatment, and clinical care. The organization serves a global community of 9,000+ MS researchers, neurologists, nurses, and allied health professionals, primarily through its flagship annual congress (recognized as the premier global MS meeting), the year-round ECTRIMS 365 / myECTRIMS digital learning platform, fellowship programmes spanning six tracks (Postdoctoral Research, Clinical Training, Nurse/AHP, MAGNIMS MRI, MEDEN MOGAD/NMOSD, and MSIF McDonald), peer-reviewed publication via the MS Journal, NeuroWebinars, podcasts, and the NeuroNews blog. ECTRIMS also co-sponsors — with the National Multiple Sclerosis Society (US) — the International Advisory Committee on Clinical Trials in MS (IACCTMS), which develops and updates the internationally authoritative McDonald Diagnostic Criteria, with the fifth revision published in The Lancet Neurology in 2024.

ECTRIMS is structured as a professional nonprofit with a deliberately lean operating model: eight employees run the organization while secretariat and congress operations are outsourced to Congrex Switzerland AG (Basel) and Exempla Management & Consulting (Brussels, for European Affairs). Revenue is generated primarily through tiered annual congress registration fees (with discounted rates for low/lower-middle-income country delegates, young professionals born on or after 1 January 1990, and nurses), educational grants from pharmaceutical sponsors (Bristol Myers Squibb, Novartis, Roche, Sanofi, UCB, Alexion AstraZeneca Rare Disease) supporting podcasts and fellowships, and co-funded fellowship programmes with partners including MSIF, MAGNIMS, MEDEN, and The Sumaira Foundation. The pricing model is largely subscription/recurring in nature, with annual billing cadence aligned to the congress cycle. Strategic direction is set by a leadership team led by President Professor Bruno Stankoff and operational committees, with no venture capital backing, parent company, or public listing identified.

The underlying technology stack is conventional event management and content distribution infrastructure rather than a proprietary AI/ML platform; there are no disclosed APIs, SDKs, mobile applications, patents, or trademarks. The organization's defensibility rests on institutional authority (McDonald Criteria stewardship), network density (the annual congress as the dominant MS research venue), and multi-decade brand reputation rather than on technology differentiation. ECTRIMS operates with global reach across Europe (Switzerland, Belgium), North America (Toronto 2026 congress), and beyond, with no geographic restrictions in its mission scope.

Name

ECTRIMS

Legal name

European Committee for Treatment and Research in Multiple Sclerosis

Website

https://ectrims.eu

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

1–10 employees

Short description

ECTRIMS is the world's largest professional organization dedicated to multiple sclerosis, operating its flagship annual congress for 9,000+ researchers and clinicians and co-authoring the internationally authoritative McDonald Diagnostic Criteria. Headquartered in Basel, Switzerland as a nonprofit, it delivers year-round education, fellowships, and clinical guidelines to the global MS community.

Ownership category

akta.pro rank

Product category

Professional Medical Society - Neurology / Multiple Sclerosis

NAICS

Other Schools and Instruction (6116), Professional, Scientific, and Technical Services (54)

SIC

Services-Membership Organizations (8600), Services-Educational Services (8200)

akta.pro primary industry

Continuing Education (CE/CPD) & Provider Accreditation Bodies (EDADACAF)

Keywords

• Medical congress
• Professional society
• Neurology education
• Clinical guidelines
• Research fellowships

Headquarters

HQ city

Basel

HQ country

Switzerland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Others

Revenue model

1. Annual Congress Registration: Revenue generated from registration fees for the annual congress, which is the world's largest MS event bringing together 9,000+ specialists. Reduced rates available for participants from low and lower-middle income countries, young delegates, and nurses.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

ECTRIMS operates as a professional membership organization that convenes the world's largest annual multiple sclerosis congress and delivers year-round educational programming for the MS research and clinical community. Its core offerings include the Annual Congress, ECTRIMS 365/myECTRIMS learning platform, fellowship programs, schools and workshops, the MS Journal, and the McDonald Diagnostic Criteria — the internationally recognized standard for MS diagnosis.

Product overview

ECTRIMS (European Committee for Treatment and Research in Multiple Sclerosis) is the world's largest professional organization dedicated to understanding and treatment of multiple sclerosis. The organization operates as a membership-based professional society offering a portfolio of interconnected products and services centered on its Annual Congress (the premier global MS event with 9,000+ attendees), the year-round ECTRIMS 365/myECTRIMS learning platform (providing fellowships, workshops, podcasts, webinars, and online resources), the peer-reviewed MS Journal, and clinical guidelines including the McDonald Diagnostic Criteria. The organization also facilitates Patient Community Day and maintains a NeuroNews blog for disseminating research and organizational updates.

Differentiator

Problem solved

Functional benefit

Products and services

• ECTRIMS Annual Congress The premier global MS research and clinical congress bringing together 9,000+ specialists with educational sessions, plenary lectures, posters, young investigator sessions, and meet-the-expert opportunities.
• ECTRIMS 365 / myECTRIMS

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Seven partnerships are on record, tiered core and minor.

• National Multiple Sclerosis Society (US)coreStrategic or Co-development Partner · 18 September 2024Co-sponsor of the International Advisory Committee on Clinical Trials in Multiple Sclerosis (IACCTMS), which is responsible for developing and updating the McDonald Diagnostic Criteria. The partnership has led to significant advances in standardizing MS diagnosis globally.
• MAGNIMS (European Magnetic Resonance Imaging in MS network)coreStrategic or Co-development PartnerJoint fellowship programme supporting young researchers in MS through projects at host institutions within the MAGNIMS network in Europe. Partners on MRI-related research and diagnostic criteria development.
• MSIF (Multiple Sclerosis International Federation)coreStrategic or Co-development PartnerJoint MSIF-ECTRIMS McDonald Fellowship enabling early career MS researchers from low- and middle-income countries to work at research institutions outside their own country for two-year programmes.
• MEDEN (MOGAD Eugene Devic European Network)coreStrategic or Co-development PartnerJoint fellowship between ECTRIMS and MEDEN focusing on neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte antibody associated disorder (MOGAD) research among clinicians and scientists across Europe.
• ACTRIMS (Americas Committee for Treatment and Research in Multiple Sclerosis)coreStrategic or Co-development PartnerJoint congress partnership for MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting to be held in Toronto, Canada from 21-23 October 2026, uniting researchers, clinicians, and healthcare practitioners globally.
• RiMS (Rehabilitation in MS)minorStrategic or Co-development PartnerCollaboration on webinars focusing on synergetic effects of Disease-Modifying Therapies and rehabilitation in Multiple Sclerosis.
• Congrex Switzerland AGcoreImplementation/ SI/ Consulting PartnerProfessional conference and event management company serving as the ECTRIMS Secretariat, handling operational management, congress organization, and administrative functions.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• European Stroke Organisation (ESO): ESO is a European professional society for stroke specialists. It is comparable to ECTRIMS as a regional medical society operating annual congresses, educational programmes, and clinical guidelines.
• Movement Disorder Society (MDS): MDS is a parallel professional society model focused on movement disorders rather than MS. Comparable in operating model — international congress, fellowships, journals, clinical guidelines — but in an adjacent neurology niche.
• European Academy of Neurology (EAN): EAN is the pan-European neurology society covering all neurological subspecialties. It overlaps with ECTRIMS on European neurologist membership and continental congress activity.
• American Academy of Neurology (AAN): AAN is the largest US-based neurology professional society with a much broader remit than MS alone. It competes for neurologist mindshare, CME dollars, and annual congress attendance.

Direct peers

• Multiple Sclerosis International Federation (MSIF): MSIF is a global MS umbrella body that partners with ECTRIMS on the McDonald Fellowship and international MS advocacy. It is comparable as a peer organization in the global MS ecosystem.
• National Multiple Sclerosis Society (NMSS): NMSS is a core strategic partner of ECTRIMS (co-sponsor of McDonald Criteria/IACCTMS) and a leading MS patient/professional organization. It is directly comparable in mission and influence, though oriented more to US patients and fundraising.
• MAGNIMS (European Magnetic Resonance Imaging in MS network): MAGNIMS is a core research partner running a joint MRI fellowship with ECTRIMS. It is directly comparable as a specialized MS research network producing MRI diagnostic standards.
• ACTRIMS (Americas Committee for Treatment and Research in Multiple Sclerosis): ACTRIMS is the Americas counterpart to ECTRIMS, running its own annual MS-focused meetings and joint congresses with ECTRIMS. It is the most direct peer in MS professional education and research convening.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks4 records

Key highlights6 records

Customer concentration

• Xx.com/ECTRIMS
• YouTubeyoutube.com/@ectrimsYouTube
• Facebookfacebook.com/ECTRIMS
• LinkedInlinkedin.com/company/ectrims

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ECTRIMS